Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Skin Cancer Program is a leading innovator in the research and treatment of skin cancer, including melanoma, basal cell carcinoma, squamous cell carcinoma, Merkel cell carcinoma, and cutaneous lymphoma. Through ongoing research and development, our team is improving the diagnosis of skin cancer and advancing the field of treatment options.
The doctors of the Stanford Skin Cancer Program lead the field in the treatment of both melanoma and non-melanoma cancers. From the utilization of novel imaging modalities to innovative chemoprevention trials, program specialists are dedicated to advancing the diagnosis, treatment, and prevention options for individuals with these rare and often complex forms of skin cancer.
Our melanoma program has a strong multidisciplinary focus involving dermatology, medical and surgical oncology, dermatopathology, nuclear medicine, and radiation oncology. Specialists have great expertise in prevention, early detection, and management of localized and metastatic melanoma.
The Stanford Cancer Center's Skin Cancer Tumor Board provide a thorough and collaborative plan for each patient.
Our non-melanoma skin cancer program encompasses dermatologic and Moh's micrographic surgery for the treatment of basal cell and squamous cell carcinomas as well as other non-melanoma skin cancers and an interdisciplinary approach to Merkel cell carcinoma, which is rare but increasing in incidence.
Skin cancer expertise at Stanford
Our goal is to transform scientific advances at Stanford University in the understanding and causes of skin cancer and discovery of mechanisms of disease into new approaches in diagnosis and treatment for our patients through:
Innovative surveillance and staging techniques such as total body digital mole mapping for early detection of melanoma and sentinel lymph node (SLN) biopsy with novel imaging modalities to improve accuracy
Immunotherapies that are both FDA-approved and in development, including leading a novel trial of ipilimumab in conjunction with palliative radiation therapy for metastatic melanoma patients
New radiologic tracers for detection of both early and advanced skin diseases
Ongoing clinical trials to test a new class of agents in basal cell carcinoma patients
Specialized skin cancer clinics
Learn more about our specialized skin cancer clinics:
For patients suffering from skin conditions associated with some cancers and treatments, the Stanford Cancer Center offers reassuring care at its Supportive Dermato-Oncology Clinic.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.